JPMorgan Resumes Allergen (AGN) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
UBS Cuts Allergan (AGN) PT, Ests But Remains Above Consensus
April 7, 2016 8:41 AM EDTUBS analyst, Marc Goodman, cited Allergen (NYSE: AGN) as a standalone company as one of his favorites. He thinks management said all the right things regarding capital deployment, M&A aggressiveness, cost cutting, its commitment to a R&D-driven business model, and its preparedness for this contingency (i.e., a deal break).... More
Susquehanna Downgrades Allergen (AGN) to Neutral
April 7, 2016 7:30 AM EDTSusquehanna downgraded Allergen (NYSE: AGN) from Positive to Neutral.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $244.74 yesterday.
... MoreAllergan (AGN) Affirms Termination of Pfizer (PFE) Merger; Affirms Strength as Standalone Company
April 6, 2016 6:47 AM EDTAllergan plc (NYSE: AGN) announced that its merger agreement with Pfizer (NYSE: PFE) has been terminated by mutual agreement, effective . In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.
Allergan reiterated its compelling standalone growth profile and strategy following the announced termination of the combination of the two companies. Allergan is positioned to drive strong, sustainable growth powered by leading franchises, new potential blockbuster product launches and unmatched pipeline.
"While we... More
Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)
April 6, 2016 6:45 AM EDTPfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the companies concluded qualified as an Adverse Tax Law Change... More
